Technology news and discussion on TalkFuse.
Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO
Isomorphic Labs has raised $5 billion in a funding round to advance AI-designed medicines. The company, founded by Demis Hassabis, says the money will support its drug design work and move its first treatments towards clinical trials.
The Series C was co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and Alphabet. Hassabis stepped back as Google DeepMind CEO three and a half months ago but remains Isomorphic’s CEO; the company spun out of DeepMind in 2021. Drug discovery startups have raised a record $23.2 billion in 2026, while Isomorphic’s previous round was $2.1 billion in May.
In short
- Isomorphic Labs raised $5 billion to develop medicines using AI.
- Hassabis remains CEO after stepping back from Google DeepMind.
- Drug discovery startups have raised a record $23.2 billion this year.
AI Business Companies Technology